Liquid biopsy is a potentially useful tool for melanoma patients, also for detecting BRAS/NRAS mutations, even if the tissue analysis remains the current standard.
Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR
Giunta, Emilio Francesco;De Falco, Vincenzo;Guerrera, Luigi Pio;Suarato, Gabriella;Napolitano, Rossella;Perrone, Alessandra;Argenziano, Giuseppe;Franco, Renato;Caraglia, Michele;Martinelli, Erika;Ciardiello, Davide;Ciardiello, Fortunato;Napolitano, Stefania;Troiani, Teresa
2022
Abstract
Liquid biopsy is a potentially useful tool for melanoma patients, also for detecting BRAS/NRAS mutations, even if the tissue analysis remains the current standard.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
